SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F691B50309F354BD610CF331934EDF15D16B53CFF87C20C8A92FF221F0BC9D1791D6AABE28ABBB08B4829963A0E9BAB8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F691B50309F354BD610CF331934EDF15D16B53CFF87C20C8A92FF221F0BC9D1791D6AABE28ABBB08B4829963A0E9BAB8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F691B50309F354BD610CF331934EDF15D16B53CFF87C20C8A92FF221F0BC9D1791D6AABE28ABBB08B4829963A0E9BAB8
http://www.w3.org/2000/01/rdf-schema#comment
"In neuroblastic tumors MYCN amplification was detected in 35.3% of the cases whereas 1p36 deletion and 17q23 gain was observed in 46.8% and 58.3% of the cases"
xsd:string
http://purl.uniprot.org/uniprot/#_82BFE360D417195E0FA89239A27F9EAEDF6C1EAADC0E9AD51AE3ACE5B40A9E43DE5017B160FFC3D8C7B6861A45F0DB90
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F691B50309F354BD610CF331934EDF15D16B53CFF87C20C8A92FF221F0BC9D1791D6AABE28ABBB08B4829963A0E9BAB8
http://purl.uniprot.org/uniprot/P04198
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F691B50309F354BD610CF331934EDF15D16B53CFF87C20C8A92FF221F0BC9D1791D6AABE28ABBB08B4829963A0E9BAB8
http://purl.uniprot.org/uniprot/#_P04198-mappedCitation-19006223
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F691B50309F354BD610CF331934EDF15D16B53CFF87C20C8A92FF221F0BC9D1791D6AABE28ABBB08B4829963A0E9BAB8